Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Monotherapy Extension for Partial Seizures
NCT00596466Phase 3Completed
- Sponsor
- Viatris
- Start
- Apr 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in focal seizures, sponsored by Viatris. Primary endpoints: Seizure Frequency, Number of Participants With Adverse Events and Serious Adverse Events and 1 more. Started Apr 2008; status: completed.
02
Drugs
pregabalin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00596466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596466.